Portfolio, January 10, 2014 (featuring a trade!)
S&P 500: 1842 (131.1%)
Portfolio: $771,287 (154.3%)
IBB 1153 shares $274,356
FSAVX sold
IAI 5675 shares $219,004
PGJ 7750 shares $237,522
Cash $40,405
Notes: The portfolio has made its first trade in months, as FSAVX has not performed as well as top funds/ETFs in recent months. The portfolio has done well even since the January 2 update, in large part due to its biotech stake.
Stocks? Pt. 4
Through the last year, the S&P 500 is up from 1462 to 1832 (25.3%), while the Morningstar value portfolio is up 21.2%.
Of the stocks in the original portfolio, Facebook nearly doubled (99%), Amazon was up by 55%, and Applied Materials was up 50%. Other significant gainers included Microsoft, John Wiley General Dynamics, Amgen, and Bank of New York. Unfortunately, Potash lost 21%, and Weight Watchers lost 40% over the same period.
The portfolio as a whole slightly underperformed the S&P 500 in a relative bull market, suggesting that blindly purchasing a portfolio of stocks meeting Morningstar’s value criteria may not be an optimal investment strategy, at least in the bull market of the past year.
Portfolio, January 1, 2014
S&P 500: 1832 (130.36%)
Portfolio: $751,762 (150.3%)
IBB 1153 shares $261,823
FSAVX 3820 shares $212,850
PGJ 7750 shares $236,607
Cash $40,480
Notes: The portfolio has not made any changes since the October 1 update, and has outperformed the S&P 500 by 66% since beginning this blog. The portfolio lagged the S&P 500 in October, but outperformed in November and December, as reflected in the chart below:

